.jpg "Michael Y. Wang, MD photo")
Professor
University of Miami
Miami, Florida, United States
Dr. Wang was born in Scottsdale, Arizona and spent his childhood in Atlanta, Georgia. He then attended Stanford University in Palo Alto, California where received both his BS and MD degrees. He completed his residency at the University of Southern California/LA County General Hospital and Fellowship at the University of Miami under Drs. Barth Green and Allan Levi. He then went on to become the Spine Program Director and Spine Fellowship Director at the USC. In 2007 he moved to South Florida and currently serves as a Professor in the Departments of Neurological Surgery and Rehabilitation Medicine at the University of Miami, Miller School of Medicine. He is the Director of Neurosurgery at University of Miami Hospital and the Spine Fellowship Director.
Dr. Wang has been an advocate for neurosurgeons and spinal surgeons. He was elected to the AANS Young Neurosurgeons Executive Committee in 2003, and in the AANS he has served as Local Host for the 2010 Annual Meeting, on the Member Benefits Committee, the Joint Sponsorship Committee, the AANS Development Committee, the International Committee, and the Scientific Program Committee. In the AANS/CNS Joint Section on Disorders of the Spine & Peripheral Nerves he has served as Chair of the Committees on Publications, Education, Fellowship, and Exhibits. He has been Scientific Program Chair, Annual Meeting Chair, Treasurer, and Chair. In the CNS he has served as the Membership Chair and Public Relations Chair. He has been Secretary/Treasurer, Vice President, and President of the Society of University Neurosurgeons (SUNS). Within the North American Spine Society (NASS) he served as the Chair of the MIP (minimally invasive procedures). He has served in numerous other leadership roles in the International Society for the Advancement of Spinal Surgery (ISASS), Society for Minimally Invasive Spine Surgery (SMISS), the USA Enhanced Recovery After Surgery (ERAS) Society, and the International Spine Study Group (ISSG).
Dr. Wang sat on several editorial review boards, including Neurosurgery, The Journal of Spinal Disorders & Techniques, World Neurosurgery, Acta Neurochirurgica, Spinal Cord, the Journal of Spinal Cord Medicine, Neurosurgical Focus, Contemporary Spine Surgery, and the Journal of Neurosurgery: Spine. His research and clinical interests include minimally invasive spinal surgery, spinal deformity, new technologies, ERAS, robotics, and spinal cord injury biomarkers. He has edited 12 medical textbooks and authored over 600 publications in the medical literature, over 200 of which are peer-reviewed.
Global Spine Health: The Way Forward
Friday, April 21, 2023
7:33am – 7:48am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
Multilevel Cervical Disc Arthroplasty
Friday, April 21, 2023
7:48am – 8:03am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
Radiation Safety in Spine Surgery
Friday, April 21, 2023
8:03am – 8:18am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
Friday, April 21, 2023
8:18am – 8:32am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
(PC2202) Practical Clinic: Problems and Solutions
Friday, April 21, 2023
8:00am – 11:30am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
Saturday, April 22, 2023
7:30am – 8:15am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
(PS1) Introduction: AANS Cushing Award for Technical Excellence and Innovation in Neurosurgery
Saturday, April 22, 2023
11:10am – 11:12am PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)
Saturday, April 22, 2023
4:20pm – 4:30pm PST
Disclosure(s): Depuy-Synthes: Consultant (Ongoing), Royalty Recipient (Ongoing); Kinesiometrics: Stock Shareholder (excluding mutual funds) (Ongoing); NuVasive: Consultant (Ongoing); Pacira Pharmaceuticals: Consultant (Ongoing); Spineology: Consultant (Ongoing); Spinicity/ISD: Stock Shareholder (excluding mutual funds) (Ongoing); Stryker: Consultant (Ongoing); Surgalign: Consultant (Ongoing)